ArticleDiabetologia2025

Treatment discontinuation among users of GLP-1 receptor agonists and SGLT2 inhibitors in a national population of individuals with type 2 diabetes.

Carl-Emil Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.